PolyPid’s D-PLEX₁₀₀ Wins BioTech Breakthrough Award for “Therapeutics Solution of the Year”

PolyPid’s Lead Candidate Recognized for Addressing Critical Unmet Need in Surgical Site Infection Prevention Following Positive Phase 3 Results PETACH TIKVA, Israel , Nov. 06, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company focused